Figure 6.
Outcome according to ELN risk category dividing the adverse risk category in two different subgroups, ELN Adv− and the very adverse risk/ELN Adv+. (A) OS and (B) EFS of the ELN 2017 risk groups stratifying the ELN 2017 adverse risk patients in the 2 proposed groups (ELN Adv− and very adverse risk/ELN Adv+). Pairwise comparison of OS and EFS has been adjusted with the Bonferroni method. Outcome after alloSCT in both ELN Adv subgroups in terms of OS (C) and CIR and NRM (D).

Outcome according to ELN risk category dividing the adverse risk category in two different subgroups, ELN Adv− and the very adverse risk/ELN Adv+. (A) OS and (B) EFS of the ELN 2017 risk groups stratifying the ELN 2017 adverse risk patients in the 2 proposed groups (ELN Adv− and very adverse risk/ELN Adv+). Pairwise comparison of OS and EFS has been adjusted with the Bonferroni method. Outcome after alloSCT in both ELN Adv subgroups in terms of OS (C) and CIR and NRM (D).

Close Modal

or Create an Account

Close Modal
Close Modal